Effectiveness of Bumetanide Infusion in Treatment of Generalized Edema and Congestive Heart Failure

Anil K. Mandal

Putnam Community Medical Center, Palatka, Florida, USA.

DOI: 10.4236/ojim.2014.43012                

Abstract

Generalized edema (anasarca) is common in nephrotic syndrome which rarely produces shortness of breath. Increased shortness of breath associated with rapid weight gain and generalized edema signify congestive heart failure (CHF). Loop diuretics consisting of furosemide (Lasix^®), bumetanide (Bumex^®), torsemide (Demadex^®) or ethacrynic acid (Edecrin) are effective diuretics to treat anasarca. However, efficacy varies depending on the renal function. Loop diuretic given orally or by intravenous boluses produce good urine output but overall response in reducing edema or shortness of breath as in CHF is less than optimum. Although literature information is very limited, continuous bumetanide infusion for 72 to 96 hours is found to be very effective in producing subjective relief of shortness of breath as well as objective improvement such as reduction in brain natriuretic peptide in CHF and improved kidney function, so that diuresis is sustained even after discontinuation of the infusion. Decrease in kidney function and electrolytes and acid-base imbalance are common but they are reversible with prompt replacement therapy. They pose no threat to life.

Keywords

Bumetanide Infusion, Generalized Edema, Congestive Heart Failure

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Brater, D.C. (1998) Diuretic Therapy. The New England Journal of Medicine, 339, 387-395. http://dx.doi.org/10.1056/NEJM199808063390607
[2]	Voelker, J.R., Cartwright-Brown, D., Anderson, S., Leinfelder, J., Sica, D.A., Kokko, J.P., Brater, D.C. (1987) Comparison of Loop Diuretics in Patients with Chronic Renal Insufficiency. Kidney International, 32, 572-578. http://dx.doi.org/10.1038/ki.1987.246
[3]	Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., Jessup, M., Konstam, M.A., Mancini, D.M., Michl, K., Oates, J.A., Rahko, P.S., Silver, M.A., Stevenson, L.W. and Yancy, C.W. (2009) Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119, e391-e479. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192065
[4]	Dargie, H.J., Marjorie, E.M., Allison, A., Kennedy, Mary, C.J. and Gray, B. (1972) High Dosage Metolazone in Chronic Renal Failure. British Medical Journal, 2, 196-198. http://dx.doi.org/10.1136/bmj.4.5834.196
[5]	Salvador, D., Rey, N.R., Ramos, C.A.C. and Punzalan, F.E. (2005) Continuous Infusion versus Bolus Injection of Loop Diuretics in Congestive Heart Failure. Cochrane Database of Systematic Reviews, 1, Article ID: CD003178.
[6]	Rudy, D.W., Voelker, J.R., Greene, P.K., Esparza, F.A., Brater, D.C. (1991) Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious than Bolus Therapy. Annals of Internal Medicine, 115, 360-366. http://dx.doi.org/10.7326/0003-4819-115-5-360
[7]	Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., LeWinter, M.M., Deswal, A., Rouleau, J.L., Ofili, E.O., Anstrom, K.J., Hernandez, A.F., McNulty, S.E., Velazquez, E.J., Kfoury, A.G., Chen, H.H., Givertz, M.M., Semigran, M.J., Bart, B.A., Mascette, A.M., Braunwald, E., O’Connor, C.M., NHLBI Heart Failure Clinical Research Network (2011) Diuretic Strategies in Patients with Acute Decompensated Heart Failure. The New England Journal of Medicine, 364, 797-805.
[8]	Inoue, M., Okajima, K., Itoh, K., Ando, Y., Watanabe, N., Yasaka, T., Nagase, S. and Morino, Y. (1987) Mechanism of Furosemide Resistance in Analbuminemic Rats and Hypoalbuminemic Patients. Kidney International, 32, 198-203. http://dx.doi.org/10.1038/ki.1987.192
[9]	Gallagher, K.L. and Jones, J.K. (1979) Furosemide Ototoxicity. Annals of Internal Medicine, 91, 744-745. http://dx.doi.org/10.7326/0003-4819-91-5-744